Literature DB >> 2825961

Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE).

Y Shimamura1, P Gunvèn, Y Takenaka, H Shimizu, Y Shima, H Akimoto, K Arima, A Takahashi, T Kitaya, T Matsuyama.   

Abstract

Patients with primary and a few with secondary liver tumors were embolized through the hepatic artery. Lipiodol and doxorubicin occluded peripherally, which was immediately followed by central embolization with gelatin sponge cubes. Preoperative embolizations were made for diagnostic and possible surgical adjuvant purposes. Extensive postembolization necrosis was common in tumors less than 5 cm in diameter, and tumor markers usually decreased temporarily after treatment. There were moderate side effects of pain, fever and nausea, and an acceptable complication and mortality rate with no deaths after embolization alone. This warrants further research on the method, which also seemed to improve the detection rate for small hepatocellular carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2825961     DOI: 10.1002/1097-0142(19880115)61:2<238::aid-cncr2820610206>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage.

Authors:  G Tocci; A Conte; P Guarascio; G Visco
Journal:  BMJ       Date:  1990-03-10

2.  Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma.

Authors:  T Ichikawa; T Yamada; H Takagi; T Abe; H Ito; S Sakurai; T Nagamine; M Mori
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

3.  Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model.

Authors:  Yuki Tomozawa; Norihisa Nitta; Shinji Ohta; Hideji Otani; Shobu Watanabe; Akinaga Sonoda; Keiko Tsuchiya; Ayumi Nitta-Seko; Masashi Takahashi; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2013-07-05       Impact factor: 2.374

4.  The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.

Authors:  B Ringe; C Wittekind; W O Bechstein; H Bunzendahl; R Pichlmayr
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

5.  Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.

Authors:  Y Horiguchi; M Itoh; H Takagawa; H Imai; A Kamei; B Sekoguchi; Y Nagamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K Jinno; S Moriwaki; M Tanada; T Wada; K Mandai; Y Okada
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.

Authors:  Kazuhiro Kasai; Akira Ushio; Yukiho Kasai; Kei Sawara; Yasuhiro Miyamoto; Kanta Oikawa; Yasuhiro Takikawa; Kazuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma.

Authors:  Yasutaka Baba; Sadao Hayashi; Kazuto Ueno; Masayuki Nakajo; Shinichi Ueno; Fumitake Kubo; Yoshirou Baba; Masahiro Hamanoue; Susumu Hasegawa; Hirohito Tsubouchi; Yasuji Komorizono
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

9.  Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.

Authors:  Avo Artinyan; Rebecca Nelson; Perry Soriano; Vincent Chung; Janet Retseck; Jonathon Reynolds; Howard Marx; Joseph Kim; Lawrence Wagman
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.

Authors:  S Kawai; J Okamura; M Ogawa; Y Ohashi; M Tani; J Inoue; Y Kawarada; M Kusano; Y Kubo; C Kuroda
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.